{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2896, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/2VpQ1nTQJxW2viVrYDQf_Mgrk5YmyuJD4DU_idGefYA/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNGRlMDdmYmVhOWVhZGVkYTQ0Y2M5OWY5MTA2OTEwMS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/1", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "44c8839e-9cbe-482a-a2a3-ee6001e67959", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide and a disclaimer, followed by an overview of the company's performance.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/zN7QY87ITGt8fD45SgMl4xC2jqQJESxfHI6idxaOiIM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNGRlMDdmYmVhOWVhZGVkYTQ0Y2M5OWY5MTA2OTEwMS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/oyQ-EOPmuQLf6kq8kh-EZe4MiGK-Zc9w-UhYhCsHC-w/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNGRlMDdmYmVhOWVhZGVkYTQ0Y2M5OWY5MTA2OTEwMS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/Mz3S1Xqael5Q6mD461ZTjqqH3SHKCmNwbljZV0OimM0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wNGRlMDdmYmVhOWVhZGVkYTQ0Y2M5OWY5MTA2OTEwMS9wMDAxLnBuZw" }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/2", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "44c8839e-9cbe-482a-a2a3-ee6001e67959", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide and a disclaimer, followed by an overview of the company's performance.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "kpi_overview", "function": "summarize", "notes": "The slide uses a background image of lab personnel to reinforce the context of clinical/biotech operations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/3", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "44c8839e-9cbe-482a-a2a3-ee6001e67959", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "The presentation starts with a cover slide and a disclaimer, followed by an overview of the company's performance.", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "propose_solution", "function": "present_framework", "notes": "The diagram is a custom funnel/process flow visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/4", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-4", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "a76c8564-6a45-42ee-b226-2a06f1cb9e24", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The company highlights its proven technology leader position in antibody discovery and its diversified portfolio.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "other", "function": "summarize", "notes": "The slide uses a grid-like layout to display partner logos and deal details (multi-target/multi-year vs single target, and therapeutic focus).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/5", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-5", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "a76c8564-6a45-42ee-b226-2a06f1cb9e24", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The company highlights its proven technology leader position in antibody discovery and its diversified portfolio.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a radial chart to show therapeutic area distribution and a nested donut/arc to show health focus (human vs animal).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/6", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-6", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "a76c8564-6a45-42ee-b226-2a06f1cb9e24", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "The company highlights its proven technology leader position in antibody discovery and its diversified portfolio.", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "revenue_buildup", "function": "quantify_opportunity", "notes": "The chart uses a stacked bar approach to show revenue components over time, with specific callouts for total values of research fees, clinical milestones, and royalties.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/7", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-7", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The chart uses a timeline axis (3m to 24m) and maps revenue streams to specific development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/8", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-8", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/9", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-9", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a box plot to visualize the distribution of royalty rates across two time periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/10", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-10", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "revenue_buildup", "function": "quantify_opportunity", "notes": "The chart is a stacked bar representation of milestone payments by stage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/11", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-11", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "comparison_table", "function": "compare_peers", "notes": "The chart uses a logarithmic-style vertical axis to show potency differences, with Bebtelovimab as the baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/12", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-12", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses visual representations of molecular structures to illustrate the focus areas.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/13", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-13", "loopMatches": [ { "to": 13, "from": 4, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "c116a9b9-66b9-474f-8411-60fed0150046", "evidence": "The presentation explains the company's technology and its applications.", "position": 0, "objective": "Why AbCellera's technology is important for antibody discovery", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.7, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" }, { "to": 13, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5", "evidence": "The presentation highlights the benefits of partnering with AbCellera.", "position": 1, "objective": "The potential consequences of not partnering with AbCellera", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 13, "from": 7, "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/14", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to distinguish between programs with and without downstream participation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/15", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide provides a snapshot of the company's clinical pipeline as of February 24, 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/16", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a waterfall-style bridge to connect the segments between years.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/17", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a waterfall-style annotation to show the delta between 2020 and 2021 values.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/18", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a side-by-side bar chart comparison for three distinct financial metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/19", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart illustrates the cash flow bridge for the full year 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/20", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-118b-7459-8ccb-22724833fcd4", "docSlug": "04de07fbea9eadeda44cc99f91069101", "documentTitle": "AbCellera | Results Presentation Deck | 21 slides", "authorId": "abcellera", "authorName": "AbCellera", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/21", "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4", "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 14, "beatId": "1d52473c-46f8-4b38-9fbe-1067a5350aa6", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "The presentation concludes with an update on the company's financials and a thank you note.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/X2w7AzTIso2aHwftJHSYQjISuYIeyVaobR7zYiMcnZk/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iY2NhMGNiN2RhZGUxOWQ5ZjYzNzQ3NzIzODcxNGM2OC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/1", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/pyKBE0hQy1do-DUNIYL4I66bexXBqQF3U1zmd0fQ6BU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iY2NhMGNiN2RhZGUxOWQ5ZjYzNzQ3NzIzODcxNGM2OC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/9hlPDWlZeWIoQioswq9osnB_I9eW-F-eBGwRFTAnyVw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iY2NhMGNiN2RhZGUxOWQ5ZjYzNzQ3NzIzODcxNGM2OC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/QKtAApWyqxR70uGrYuDj2qvngswGJsjlbv1yz4VUvXQ/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iY2NhMGNiN2RhZGUxOWQ5ZjYzNzQ3NzIzODcxNGM2OC9wMDAxLnBuZw" }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/2", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/3", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/4", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/5", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "problem_statement", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/6", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "c8c7da75-4a0c-483f-94bc-e6a4117ad71e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem Statement", "beatSlug": null, "evidence": "The deck clearly states the problem of Arginase 1 Deficiency and its effects on patients", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "frame_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/7", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "c8c7da75-4a0c-483f-94bc-e6a4117ad71e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem Statement", "beatSlug": null, "evidence": "The deck clearly states the problem of Arginase 1 Deficiency and its effects on patients", "position": 0, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 8, "from": 7, "beatId": "c7df3ef4-d7aa-4c6a-a90f-21d191eea2e4", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Key Messages", "beatSlug": null, "evidence": "The deck provides key messages about ARG1-D diagnosis and management", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_messages", "function": "diagnose_problem", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/8", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 8, "from": 7, "beatId": "c7df3ef4-d7aa-4c6a-a90f-21d191eea2e4", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Key Messages", "beatSlug": null, "evidence": "The deck provides key messages about ARG1-D diagnosis and management", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/9", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "customer_journey", "function": "illustrate_case", "notes": "The slide uses a narrative structure to outline the patient's clinical progression from birth to genetic diagnosis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/10", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 10, "beatId": "0880872a-b0b7-498c-bff6-163b46508334", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Patient Medical History", "beatSlug": null, "evidence": "The deck provides a detailed patient medical history", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "customer_journey", "function": "diagnose_problem", "notes": "The slide uses a timeline framework to map clinical events against age in years.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/11", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 11, "from": 10, "beatId": "0880872a-b0b7-498c-bff6-163b46508334", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Patient Medical History", "beatSlug": null, "evidence": "The deck provides a detailed patient medical history", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "diagnose_problem", "notes": "The slide uses a narrative structure to explain the diagnostic journey from initial symptoms to definitive genetic confirmation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/12", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "before_after", "function": "diagnose_problem", "notes": "The slide uses a before-after framework to demonstrate the efficacy of the treatment plan.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/13", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 13, "beatId": "ca33b19f-f6f8-471d-acf4-c7eaa3177057", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Diagnostic Methods and Biochemistry Labs", "beatSlug": null, "evidence": "The deck shows the effectiveness of diagnostic methods and biochemistry labs", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "other", "function": "analyze_data", "notes": "The chart tracks patient data from 2007 to 2021 with specific clinical annotations explaining fluctuations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/14", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "summarize", "notes": "Clinical case study summary slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/15", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/16", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 16, "from": 16, "beatId": "fb92716a-1439-4446-9fb5-f877b7740d2b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Summary and Conclusions", "beatSlug": null, "evidence": "The deck provides summary and conclusions about the potential of the therapy", "position": 5, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "The slide uses a vertical icon-based process flow to connect clinical facts to the conclusion.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/17", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-17", "loopMatches": [ { "to": 17, "from": 17, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ea540d90-0192-4c0c-aee8-a16c8ad598b1", "evidence": "The deck highlights the debilitating effects of ARG1-D on patients' quality of life", "position": 0, "objective": "Highlight the cost of inaction for patients with ARG1-D", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/18", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/19", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes patient photo and clinical data table comparing normal ranges to patient baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/20", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/21", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-21", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 21, "from": 21, "beatId": "58843c7c-2fb4-4f23-b948-1e8f60ffbb00", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Pegzilarginase Program Overview", "beatSlug": null, "evidence": "The deck provides an overview of the Pegzilarginase program", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the clinical trial structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/22", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-22", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "present_framework", "notes": "The slide uses a combination of medical classification (GMFCS) and functional assessment tools (GMFM, Timed Walk Tests) to quantify mobility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/23", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-23", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Clinical trial safety data presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/24", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-24", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses box plots to show distribution, with specific clinical guideline and normal range thresholds marked.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/25", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-25", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide highlights the efficacy of pegzilarginase in a clinical setting.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/26", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-26", "loopMatches": [ { "to": 26, "from": 21, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "9cc0cacb-1c5c-40f5-a519-d219894ab0a2", "evidence": "The deck provides clinical data supporting the effectiveness of Pegzilarginase", "position": 1, "objective": "Show the potential of Pegzilarginase to improve patient outcomes", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.7, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes MCID thresholds for GMFM-E (GMFCS I and II).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/27", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-27", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes study design timeline and MCID thresholds for GMFCS levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/28", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_takeaways", "function": "summarize", "notes": "Includes patient photos as visual evidence of mobility improvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/29", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/30", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": "The photo shows a child with a sign that says 'First Day of 4th GRADE' and 'I WANT TO BE A: WARRIOR SEPT. 1st 2021'.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/31", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/32", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-122c-721c-8b62-3522a74ffc66", "docSlug": "bcca0cb7dade19d9f637477238714c68", "documentTitle": "Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides", "authorId": "aeglea-biotherapeutics", "authorName": "Aeglea BioTherapeutics", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "cover", "function": "front_matter", "notes": "Contains company logo, address, website, and document reference code.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-122c-721c-8b62-3522a74ffc66/33", "deckHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66", "deckAnchorHref": "/decks/019de072-122c-721c-8b62-3522a74ffc66#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/e8wIviLdv8Hej3myQ_fSvQ7xY7xHujvxcRsCVv7OF6c/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMmRkOGQ5MmVlY2U0NzJhNTk3YmI2ZGM4Nzc0NjQzNi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/1", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/krWYskOhXUHLmx41ZW6kpbsOvdLjWkZVySAugGDTxr0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMmRkOGQ5MmVlY2U0NzJhNTk3YmI2ZGM4Nzc0NjQzNi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/6aeXm3mHot0CTCzFq7-esTnerATzPZn60UBWBL19kZI/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMmRkOGQ5MmVlY2U0NzJhNTk3YmI2ZGM4Nzc0NjQzNi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/JeGSfQW8MrJWg2yKEKFnLAJXm0zzGwwIH2zGsIz10Jo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iMmRkOGQ5MmVlY2U0NzJhNTk3YmI2ZGM4Nzc0NjQzNi9wMDAxLnBuZw" }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/2", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/3", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/4", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/5", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-131b-72bd-9b20-3d67db895ed6", "docSlug": "b2dd8d92eece472a597bb6dc87746436", "documentTitle": "Aeva | Results Presentation Deck | 16 slides", "authorId": "aeva", "authorName": "Aeva", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de072-131b-72bd-9b20-3d67db895ed6/6", "deckHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6", "deckAnchorHref": "/decks/019de072-131b-72bd-9b20-3d67db895ed6#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }